Ilika plc makes senior appointments and change of director

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has today provided an update on senior appointments and a planned change of Director.

To further support the development and commercialisation of Ilika’s solid-state battery products, Ilika has made two senior additions to its management team, creating two new positions:

Goliath Operations Director – With immediate effect, Ilika has appointed Brendan McCarthy. Brendan was most recently Operations Director at the UK Battery Industrialisation Centre (UK-BIC) and prior to that had a long career at BMW where he held a variety of UK-based and international operational roles.

VP Product Development – With effect from 1 November 2021, Ilika has appointed Robin Bell. Robin is currently Chief Operating Officer at Inflowmatix, which has recently been acquired by Suez. Prior to that, Robin was Director of Product Development at SPI Lasers (Trumpf GmbH).

Robin will take over line management responsibility for Ilika’s Stereax and Goliath product development programmes from Prof Brian Hayden, who will step down as a Statutory Director of Ilika plc at Ilika’s forthcoming AGM on 22 September 2021. Brian will retain the position of Chief Scientific Officer in the Company in a consulting role which will be focussed on delivering rapid technical solutions to the development teams.

Ilika plc CEO Graeme Purdy, stated, “We are delighted to welcome Brendan and Robin to our team. They will build on the product development momentum created so far and bring their substantial operational expertise to bear on the execution of our product roadmaps. We look forward to continuing our long relationship with Brian in his new technical consulting role.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search